Job Title: Global Insights, Analytics, and Forecasting Senior Manager, CVRM Early Assets and Business Development
Location: Central Cambridge, UK
At AstraZeneca, we\'re not afraid to do things differently. We\'re resetting expectations of what a bio-pharmaceutical company can be. This means we\'re establishing new ways to work, with ground-breaking and cutting-edge methods, and bringing unexpected teams together.
AstraZeneca is organized around two core business units: BioPharmaceuticals (BBU) and Oncology. The BBU focuses on development and commercialization of AstraZeneca\xe2\x80\x99s Respiratory, Immunology, Cardiovascular, Metabolic, Renal, and Infectious Disease therapeutic areas.
Global Insights, Analytics & Commercial Excellence (GIACE) is a strategic function, critical for enabling success in the growth of the BBU business. Our ambition is to build an industry-leading organization, empowering our Commercial teams through the generation of compelling evidence and insights, while ensuring they have the tools and skills to deliver impactful launches that change the practice of medicine for the benefit of patients. Within GIACE, the Insights, Analytics, and Forecasting (IA&F) function is organized across two teams and supports both the US and Global organizations: Respiratory & Immunology IA&F, and CVRM (Cardiovascular, Renal, Metabolic) IA&F.
Team Overview
The Global CVRM IA&F Early Assets and Business Development team serves as a strategic business partner to the CVRM Early Commercial & Strategy group and the R&D Global Product Teams, providing market insights that drive key commercial investment decisions and therapeutic area strategy development.
Together we strive to uncover deep customer insights to drive improved decision-making and business impact. We are looking for leaders who have the passion to drive business results and bring innovation to what we do for greater impact.
The Global IA&F CVRM Early Assets and Business Development Senior Manager is expected to support strategic direction to deliver competitive advantages through the application of end-to-end insights, analytics, and forecasts across both the Global and US markets to support AstraZeneca\xe2\x80\x99s industry-leading CVRM pipeline. Our mission as a team is to improve the quality of the company\xe2\x80\x99s investment decisions to support corporate growth targets. To achieve this, the CVRM Early Assets IA&F team is tasked with delivering excellence in market research, customer and competitor insights, analytics, and forecasting.
In addition to strong analytical and forecasting skills, the Global IA&F CVRM Early Assets and Business Development Senior Manager should have excellent communication skills with a demonstrated track record of effective business partnership as demonstrated by material business impact and influencing. This position may be required to manage contractors and consultants to complete projects, but will have no direct reports. The candidate will also be required to continuously evaluate new quantitative analytics methods, technologies, and datasets.
This role works closely with CVRM Early Commercial & Strategy, Medical, Epidemiology, HEOR, Market Access and Pricing, Clinical R&D, Finance, and other senior business partners throughout the organisation.
Key Responsibilities:
Serve as commercial subject matter expert in established and emerging disease areas of interest to the CVRM Early Commercial and Strategy team.
Summarize and present findings through various communication channels; be able to \xe2\x80\x9ctell the story\xe2\x80\x9d to senior commercial and clinical stakeholders
Construct patient-based forecast models in Excel that leverage credibly bold and ambitious data inputs synthesized from a variety of primary and secondary sources, and benchmarked against internal and external analogs
Utilize electronic medical records, or medical claims and laboratory data to estimate market sizes for business development opportunities or internal pipeline assets facing milestone investment decisions
Champion the use of local customer insights in strategic and operational decisions across the business
Identify and prioritize enhancements and new analytics capabilities. Can lead the development, deployment, and embedding of such capabilities across the organization.
Instill and reinforce a culture of continuous improvement, learning, testing, and deployment of new capabilities for the business
Access and evaluate appropriate information via a variety of internal and external tools and sources
Monitor the external environment to stay up to date on leading analytics and forecasting capabilities, both within and outside of pharma, which can be applied within the organization
Required experience:
3+ years of pharmaceutical industry experience leading qualitative and quantitative primary market research
Good revenue forecasting experience utilizing epidemiology-based methodologies
Familiarity with medical claims (open or closed) or electronic health record databases, IQVIA Rx and sales data, and other syndicated data.
Proficiency in extracting and interpreting insights from large longitudinal data sources, such as Claims, EMR and other patient level data sets.
Experience with MS Office products - Excel and PowerPoint skills.
Advanced modelling skills using Visual Basic, Power BI, SQL+ R or Python are desirable.
Additional Success Factors:
Excellent communication and influencing skills, combined with strong leadership and interpersonal skills and demonstrated ability to work with senior business leaders and cross-functional business partners
Strategic and critical thinking with the ability to engage, build and maintain credibility with Commercial Leadership teams
Ability to manage a diverse range of simultaneous projects, timelines, and priorities with both internal stakeholders and external vendors.
Capability in applying and deploying deep technical skills and knowledge (e.g., modelling capabilities, CVRM disease insights, or data expertise) across IA&F functional areas
Educational requirements
Bachelor\xe2\x80\x99s degree from an accredited college or university
An advanced degree is preferred (Master\xe2\x80\x99s, MBA, or PhD)
3+ years of experience in Pharmaceutical / Biotech / Healthcare analytics or secondary data analysis and forecasting
Closing date for applications: 11th August
Date Posted 16-Aug-2023
Closing Date 17-Aug-2023
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.
MNCJobs.co.uk will not be responsible for any payment made to a third-party. All Terms of Use are applicable.